The Endocrine Society’s Role in Recent LGBTQ+ Supreme Court Ruling

In a landmark ruling, the Supreme Court of the United States found that gay and transgender individuals cannot be discriminated against in the workplace on the basis of sex.

The 6-3 decision stated that Title VII of the Civil Rights Act of 1964, which prohibits discrimination “because of sex,” includes gay and transgender employees. The ruling came after consideration of three cases, including Harris Funeral Homes v Equal Employment Opportunity Commission, which was brought by Aimee Stephens, a transgender employee of Harris Funeral Homes, who was fired after she started dressing consistent with her gender identity rather than her gender at birth.

The Endocrine Society participated in this case by submitting an amicus brief in the case of Harris v EEOC. The “friend of the court” brief provided scientific background and context regarding transgender health for the court. Our clinical practice guideline, Endocrine Treatment of Gender Dysphoric/Gender Incongruent Persons, was cited in the brief and relied upon by the majority.

This ruling is expected to have far-reaching effects on regulations finalized and under consideration by the Trump Administration, including the recent rollback of protection from discrimination in the healthcare system for transgender individuals (Affordable Care Act Section 1557) that was finalized on June 12, 2020.

 

You may also like

  • Endocrine Society Launches Obesity Education Initiative for Members of Congress

    Obesity has been a crisis in the U.S. for decades and unfortunately it continues to impact millions of Americans. According to CDC data, approximately 42.4% of adults in the U.S. are obese, which has resulted in an estimated $147 billion in medical costs. There is also an alarming connection between obesity and COVID-19. People with obesity contracting COVID-19 are more likely to be hospitalized and placed in intensive care than those who are not obese. The…

  • Increased Funding for Research Remains a Top Endocrine Society Priority

    As Congress and the Biden administration begin work on the upcoming year’s (FY 2022) budget and appropriations priorities, the Endocrine Society will continue to advocate for increased research funding. As in previous years, the Endocrine Society will advocate for increased funding for the National Institutes of Health (NIH) and other federal research funding agencies that…

Find more in